Pulmonary Fibrosis: Current Understanding and Future Directions

Dear Colleagues,

This Special Issue, entitled “Pulmonary Fibrosis: Current Understanding and Future Directions”, aims to explore the multifaceted nature of interstitial lung disease (ILD) and pulmonary fibrosis, including the pathogenesis, diagnosis, and management of a wide array of inflammatory and fibrotic lung diseases. ILDs encompass a diverse group of disorders, ranging from idiopathic pulmonary fibrosis (IPF) to hypersensitivity pneumonitis, collagen tissue disease-associated ILDs, and drug-induced ILDs. Despite advances in pharmacotherapy, achieving adequate symptom control remains challenging, highlighting the need for a holistic approach that includes nutrition, rehabilitation, and innovative diagnostic techniques.

We invite submissions on a wide range of topics, including, but not limited to, the following: unclassifiable ILDs, fibrotic hypersensitivity pneumonitis, acute exacerbations, pleuroparenchymal fibroelastosis, severe immune-related adverse events in ILDs, and rehabilitation and nutrition in patients with ILDs. Additionally, we welcome research on emerging diagnostic tools, such as bronchoscopy with cryobiopsy, and novel therapeutic strategies, which are becoming increasingly important in the field.
With anticipation, we invite you to submit original research articles or reviews and other types of articles to this Special Issue. Your contributions will promote intellectual collaboration in the field of ILD, ultimately improving patient outcomes and guiding future research directions.

Dr. Satoshi Okamori
Dr. Yusuke Nakamura
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.